SI0770388T1 - Multiphase contraceptive preparation based on natural estrogens - Google Patents

Multiphase contraceptive preparation based on natural estrogens

Info

Publication number
SI0770388T1
SI0770388T1 SI9630008T SI9630008T SI0770388T1 SI 0770388 T1 SI0770388 T1 SI 0770388T1 SI 9630008 T SI9630008 T SI 9630008T SI 9630008 T SI9630008 T SI 9630008T SI 0770388 T1 SI0770388 T1 SI 0770388T1
Authority
SI
Slovenia
Prior art keywords
natural
phase
preparation based
active agent
contraceptive preparation
Prior art date
Application number
SI9630008T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Prof. Dr. Dittgen
Sabine Dr. Fricke
Herbert Prof. Dr. Hoffmann
Claudia Dr. Moore
Michael Prof. Dr. Oettel
Monika Ostertag
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7776074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0770388(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of SI0770388T1 publication Critical patent/SI0770388T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Gyroscopes (AREA)
  • Permanent Magnet Type Synchronous Machine (AREA)
  • Amplifiers (AREA)
SI9630008T 1995-10-28 1996-10-22 Multiphase contraceptive preparation based on natural estrogens SI0770388T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540253A DE19540253C2 (de) 1995-10-28 1995-10-28 Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
EP96116919A EP0770388B1 (de) 1995-10-28 1996-10-22 Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene

Publications (1)

Publication Number Publication Date
SI0770388T1 true SI0770388T1 (en) 1998-08-31

Family

ID=7776074

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630008T SI0770388T1 (en) 1995-10-28 1996-10-22 Multiphase contraceptive preparation based on natural estrogens

Country Status (18)

Country Link
US (2) US6133251A (xx)
EP (1) EP0770388B1 (xx)
JP (1) JP3020880B2 (xx)
CN (1) CN1137691C (xx)
AT (1) ATE164312T1 (xx)
CA (1) CA2188907C (xx)
CZ (1) CZ290741B6 (xx)
DE (3) DE19540253C2 (xx)
DK (1) DK0770388T3 (xx)
ES (1) ES2116804T3 (xx)
FR (1) FR09C0018I2 (xx)
HU (1) HU223753B1 (xx)
LU (1) LU91643I2 (xx)
NL (1) NL300381I2 (xx)
PL (1) PL186339B1 (xx)
RU (1) RU2113849C1 (xx)
SI (1) SI0770388T1 (xx)
SK (1) SK281709B6 (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
CA2267743C (en) 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
AU2005201151B2 (en) * 1999-03-30 2008-01-10 Jencap Research Ltd Low dose estrogen interrupted hormone replacement therapy
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
KR100857344B1 (ko) * 1999-08-31 2008-09-05 바이엘 쉐링 파마 악티엔게젤샤프트 피임약으로서의 사용을 위한 에티닐에스트라디올과드로스피렌온의 약학적 조합
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
TWI252111B (en) * 2001-12-14 2006-04-01 Solvay Pharm Gmbh Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
US20040072814A1 (en) 2002-10-11 2004-04-15 Solvay Pharmaceuticals Gmbh Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
ATE546144T1 (de) * 2005-10-13 2012-03-15 Bayer Pharma AG Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
DE4104385C1 (xx) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de) * 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4339934C2 (de) * 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
US6884793B2 (en) 2005-04-26
RU2113849C1 (ru) 1998-06-27
SK281709B6 (sk) 2001-07-10
EP0770388B1 (de) 1998-03-25
HU223753B1 (hu) 2005-01-28
HUP9602982A3 (en) 1997-10-28
DE19540253A1 (de) 1997-04-30
SK135296A3 (en) 1997-06-04
CA2188907A1 (en) 1997-04-29
PL186339B1 (pl) 2003-12-31
NL300381I1 (nl) 2009-06-02
NL300381I2 (nl) 2017-05-22
CN1159917A (zh) 1997-09-24
JP3020880B2 (ja) 2000-03-15
CZ9603043A3 (cs) 2002-01-16
EP0770388A1 (de) 1997-05-02
DE122009000011I1 (de) 2009-05-20
DE19540253C2 (de) 1998-06-04
DE122009000011I2 (de) 2011-07-21
PL316608A1 (en) 1997-05-12
DK0770388T3 (da) 1999-01-11
LU91643I2 (fr) 2010-03-29
US20020107229A1 (en) 2002-08-08
FR09C0018I1 (xx) 2009-09-25
ATE164312T1 (de) 1998-04-15
HUP9602982A2 (en) 1997-05-28
CA2188907C (en) 2001-02-27
CZ290741B6 (cs) 2002-10-16
JPH09169649A (ja) 1997-06-30
HU9602982D0 (en) 1996-12-30
ES2116804T3 (es) 1998-07-16
CN1137691C (zh) 2004-02-11
FR09C0018I2 (fr) 2015-05-22
DE59600128D1 (de) 1998-04-30
US6133251A (en) 2000-10-17

Similar Documents

Publication Publication Date Title
SI0770388T1 (en) Multiphase contraceptive preparation based on natural estrogens
AU645637B2 (en) Contraceptive regimen
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
WO1999012531A3 (de) Mittel zur hormonalen kontrazeption
CA2079002A1 (en) Ovulation-preventing agent for hormonal contraception
AU5587690A (en) Treatment of postmenopausal disorders
DE69710896D1 (en) Progestogen-anti-progestogen therapien
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
IL124472A0 (en) Contraceptive process and kit for female mammals comprising a combination of gestagen and estrogen
ATE271386T1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
AR016502A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas.
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
DE69731092D1 (de) Orales contrazeptivum
HUP9900612A3 (en) Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
PT906127E (pt) Novos dispositivos destinados a administracao transdermica da trimegestona
AU2691197A (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
MX9707009A (es) Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
王晓芬 et al. The System for Managing Reusable Object-Oriented Software Components
AR010296A1 (es) Uso de una combinacion de una progestina y un estrogeno y un equipo anticonceptivo para administracion oral

Legal Events

Date Code Title Description
SP73 Change of data on owner

Owner name: SCHERING AG; DE

Effective date: 20050831

SP73 Change of data on owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT; DE

Effective date: 20090303

SP73 Change of data on owner

Owner name: BAYER INTELLECTUAL PROPERTY GMBH; DE

Effective date: 20130329